ArticleBreast cancer research and treatment2022

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.

Marissa Meegdes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.